Guru Ownership Trend
Guru Analysis for ArriVent BioPharma, Inc. (AVBP)
ArriVent BioPharma, Inc. (AVBP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $18.36 M.
Top institutional holders include Steven Cohen and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $6.07 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 35.1%. Conversely, Steven Cohen reduced exposure by 24.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for ArriVent BioPharma, Inc. (AVBP)
Major holders include Steven Cohen ($19.69 M), Paul Tudor Jones ($808,990), Cliff Asness ($747,500). According to the latest reported data, 3 tracked investment managers collectively hold approximately 611,600 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $6.07 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited AVBP. The total reported sell value was $6.3 M.
Yes, 0 managers opened new positions in AVBP, and 2 increased their existing holdings. The total reported buy value was $235,537.03.